Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository corticotropin injection)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of particulate matter: glass and stopper piece
Products
  • Acthar Gel (repository corticotropin injection)
Where it was sold

USA Nationwide

Nationwide

Units affected
12367 vials
About this recall
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2